We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-2.62%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.84B
AUM Growth
-$154M
Cap. Flow
+$25M
Cap. Flow %
0.52%
Top 10 Hldgs %
18.29%
Holding
1,493
New
82
Increased
580
Reduced
615
Closed
118

Sector Composition

Rank Sector Weight
1 Technology 18.65%
2 Financials 10.44%
3 Healthcare 9.35%
4 Industrials 8.91%
5 Consumer Discretionary 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJS icon
1201
iShares S&P Small-Cap 600 Value ETF
IJS
$8.33B
$244K 0.01%
2,739
-181
-6% -$17.2K
FXL icon
1202
First Trust Technology AlphaDEX Fund
FXL
$2.81B
$244K 0.01%
2,194
CLB icon
1203
Core Laboratories
CLB
$568M
$243K 0.01%
10,137
-19
-0.2% -$466
TFII icon
1204
TFI International
TFII
$11.5B
$243K 0.01%
1,890
MTDR icon
1205
Matador Resources
MTDR
$6.47B
$242K 0.01%
+4,075
New +$237K
MHD icon
1206
BlackRock MuniHoldings Fund
MHD
$604M
$242K 0.01%
23,497
+3,722
+19% +$42.1K
CGSD icon
1207
Capital Group Short Duration Income ETF
CGSD
$2.44B
$240K 0.01%
+9,600
New +$242K
VTEB icon
1208
Vanguard Tax-Exempt Bond Index Fund
VTEB
$46B
$239K ﹤0.01%
4,971
+642
+15% +$31.8K
BME icon
1209
BlackRock Health Sciences Trust
BME
$577M
$239K ﹤0.01%
6,105
-575
-9% -$22.9K
BSCR icon
1210
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
$4.59B
$239K ﹤0.01%
12,733
BMRN icon
1211
BioMarin Pharmaceuticals
BMRN
$13.5B
$238K ﹤0.01%
2,694
-602
-18% -$53.6K
JPC icon
1212
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
$238K ﹤0.01%
37,649
-286
-0.8% -$1.85K
WSC icon
1213
WillScot Mobile Mini Holdings
WSC
$4.2B
$235K ﹤0.01%
5,649
-1,450
-20% -$63.8K
HIE
1214
DELISTED
Miller/Howard High Income Equity Fund
HIE
$235K ﹤0.01%
23,661
-248
-1% -$2.51K
TH icon
1215
Target Hospitality
TH
$1.67B
$234K ﹤0.01%
14,750
-2,100
-12% -$29.6K
HUSV icon
1216
First Trust Horizon Managed Volatility Domestic ETF
HUSV
$84.7M
$234K ﹤0.01%
7,497
-114
-1% -$3.7K
BERY
1217
DELISTED
Berry Global Group, Inc.
BERY
$233K ﹤0.01%
+4,100
New +$241K
SAGE
1218
DELISTED
Sage Therapeutics
SAGE
$233K ﹤0.01%
11,305
-3,508
-24% -$101K
PARAP
1219
DELISTED
Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock
PARAP
$232K ﹤0.01%
13,067
+300
+2% +$6.35K
SJM icon
1220
J.M. Smucker
SJM
$12.6B
$231K ﹤0.01%
1,882
+98
+5% +$13.9K
CCEP icon
1221
Coca-Cola Europacific Partners
CCEP
$46.4B
$231K ﹤0.01%
3,699
-33
-0.9% -$2.1K
FPX icon
1222
First Trust US Equity Opportunities ETF
FPX
$1.49B
$231K ﹤0.01%
2,752
+37
+1% +$3.25K
WTRG icon
1223
Essential Utilities
WTRG
$11.1B
$231K ﹤0.01%
6,718
BSJP
1224
DELISTED
Invesco BulletShares 2025 High Yield Corporate Bond ETF
BSJP
$230K ﹤0.01%
+10,247
New +$231K
OWL icon
1225
Blue Owl Capital
OWL
$18.8B
$230K ﹤0.01%
17,733
+3,651
+26% +$43.6K

Similar funds

Oppenheimer & Co's Q3 2023 Portfolio in Review

As of Q3 2023, Oppenheimer & Co held 1,493 positions worth $4.84B, down 3.1% from $5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q3 2023 filing shows 82 new, 580 increased, 615 reduced and 118 closed positions. Its largest new stake was FT Vest US Equity Deep Buffer ETF August: 562,231 shares worth $18.6M. The largest sale was FT Vest US Equity Deep Buffer ETF December, an estimated $15.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q3 2023 buy was FT Vest US Equity Deep Buffer ETF August: 562,231 shares worth $18.6M.
  • Oppenheimer & Co added most to ConocoPhillips in Q3 2023, an estimated $4.53M increase.
  • Oppenheimer & Co's biggest Q3 2023 reduction was Equitrans Midstream Corporation Common Stock, cutting an estimated $7.88M.
  • Oppenheimer & Co fully exited FT Vest US Equity Deep Buffer ETF December in Q3 2023, selling an estimated $15.1M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $4.84B portfolio in Q3 2023.
  • Oppenheimer & Co opened 82 new positions and closed 118 in Q3 2023.
  • Oppenheimer & Co's portfolio value fell 3.1% quarter-over-quarter to $4.84B.

Based on Oppenheimer & Co's 13F filing for Q3 2023, filed 8 Nov 2023.